Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Eagle May Launch Vasopressin ‘At-Risk’ As January Trial Looms
Additional Complex ANDAs Could Be On The Radar
Nov 03 2020
•
By
Dean Rudge
'We’re very willing partners and very good partners,' Eagle said of its complex ANDA strategy • Source: Shutterstock
More from Generics
More from Products